Physician profile
Cesar E Sanz
NPI 1174550537
$7,607.73
in general payments reported to CMS, 2019-2025
10 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,803 · 2020: $4,019 · 2021: $239 · 2022: $78.21 · 2023: $61.09 · 2024: $150 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $469.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,563.28 | 2019-2020 | |
| Medtronic, INC. | $532.60 | 2021-2025 | Signet, Ligasure, Signia |
| Biom'Up France Sas | $144.77 | 2021 | |
| Olympus America INC. | $125.00 | 2019 | |
| Acell, INC. | $118.72 | 2019 | |
| Davol INC. | $36.91 | 2025 | Arista |
| Hologic Sales and Service, LLC | $30.67 | 2024 | Localizer, Trident Specimen Radiography System |
| Stryker Corporation | $23.19 | 2024 | 1788 |
| Integra Lifesciences Corporation | $18.15 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Thd America, INC. | $14.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Sanz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.